Clinical Trials Directory

Trials / Unknown

UnknownNCT05396404

Empirical Mode Decomposition and Decision Tree in Sarcopenia

Using Empirical Mode Decomposition and Decision Tree to Extract the Balance and Gait Features and Classification in Sarcopenia

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Changhua Christian Hospital · Academic / Other
Sex
All
Age
40 Years – 90 Years
Healthy volunteers
Accepted

Summary

Sarcopenia is quickly becoming a major global public health issue. Falls are the leading cause of mortality among the elderly, and they must be addressed. The investigators will use machine learning techniques such as empirical mode decomposition technology and decision tree algorithms to extract the characteristics and classification of sarcopenia in this retrospective study in order to offer clinically proven and effective interventional strategies to prevent, stabilize, and reverse sarcopenia.

Detailed description

Sarcopenia is becoming a severe global public health concern as the world's elderly population grows. Sarcopenia is characterized by muscular mass and strength loss, as well as impaired physical performance, and it is frequently connected with negative health outcomes such as falls. Falls are a primary cause of death in older individuals and must be addressed. Sarcopenia is currently diagnosed clinically using three primary technologies: imaging technology, precision medicine, and machine learning. In this study, the investigators will use previously collected data from nearly 200 community-dwelling subjects, including medical history, biochemistry, body composition, balance and gait, electromyography, and functional performance, to extract the characteristics and classification of sarcopenia using machine learning techniques such as empirical mode decomposition technology and decision tree algorithms. The investigators intend to offer clinically proven and effective interventional strategies to prevent, stabilize, and reverse sarcopenia.

Conditions

Timeline

Start date
2022-03-01
Primary completion
2024-01-31
Completion
2024-07-01
First posted
2022-05-31
Last updated
2022-09-08

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT05396404. Inclusion in this directory is not an endorsement.